Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | malate dehydrogenase | 0.00536163 | 1 | 1 |
Plasmodium falciparum | malate dehydrogenase | 0.00536163 | 1 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase a | 0.00536163 | 1 | 1 |
Echinococcus granulosus | peroxidasin | 0.00448181 | 0.423752 | 0.423752 |
Plasmodium vivax | lactate dehydrogenase | 0.00536163 | 1 | 0.5 |
Onchocerca volvulus | Peroxidasin homolog | 0.00448181 | 0.423752 | 0.5 |
Onchocerca volvulus | Peroxidasin homolog | 0.00448181 | 0.423752 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.00448181 | 0.423752 | 0.5 |
Onchocerca volvulus | 0.00448181 | 0.423752 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.00536163 | 1 | 1 |
Schistosoma mansoni | L-lactate dehydrogenase | 0.00536163 | 1 | 1 |
Echinococcus granulosus | lactate dehydrogenase a | 0.00536163 | 1 | 1 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.00536163 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.00536163 | 1 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase protein | 0.00536163 | 1 | 1 |
Echinococcus granulosus | L lactate dehydrogenase B chain | 0.00536163 | 1 | 1 |
Plasmodium falciparum | L-lactate dehydrogenase | 0.00536163 | 1 | 0.5 |
Onchocerca volvulus | Dual oxidase homolog | 0.00448181 | 0.423752 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase protein | 0.00536163 | 1 | 1 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.00536163 | 1 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.00448181 | 0.423752 | 0.5 |
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.00536163 | 1 | 0.5 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.00448181 | 0.423752 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.00536163 | 1 | 1 |
Plasmodium vivax | malate dehydrogenase, putative | 0.00536163 | 1 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.00536163 | 1 | 1 |
Echinococcus multilocularis | peroxidasin | 0.00448181 | 0.423752 | 0.423752 |
Onchocerca volvulus | 0.00448181 | 0.423752 | 0.5 | |
Leishmania major | malate dehydrogenase, putative | 0.00536163 | 1 | 0.5 |
Onchocerca volvulus | 0.00448181 | 0.423752 | 0.5 | |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.00536163 | 1 | 0.5 |
Brugia malayi | lactate dehydrogenase. | 0.00536163 | 1 | 1 |
Echinococcus multilocularis | L lactate dehydrogenase B chain | 0.00536163 | 1 | 1 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.00536163 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 5.05 uM | Huh7 cytotoxicity for Pf inhibitors | Novartis-GNF Malaria Box. | No reference |
CC50 | = 5.05 uM | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | ChEMBL. | 18579783 |
EC50 (functional) | = 0.0626 uM | PF proliferation inhibition 3D7 | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | = 0.0626 uM | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | ChEMBL. | 18579783 |
EC50 (functional) | > 12.5 uM | W2 Pf proliferation inhibition | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | > 12.5 uM | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | ChEMBL. | 18579783 |
IFI promiscuity index | = 0.09375 | IFI promiscuity index | Novartis-GNF Malaria Box. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 18579783 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.